The centre will focus on ‘targeted protein degradation’ – one of the hottest and most promising areas in drug discovery. Scientists aim to hijack normal process of protein destruction to wipe out cancer proteins that traditional targeted drugs cannot block.

Members of the ICR’s Discovery Club were given an exclusive insight into how researchers sample, process and analyse tumour cells in the lab, as part of the ICR’s first virtual event for our donors.

Members of the ICR’s Discovery Club saw first-hand the delicacy and complexity of techniques used to sculpt new drug molecules, as they learned how our scientists design the cancer drugs of the future.